The glutamatergic system as potential clinical biomarkers for blood and cerebrospinal fluid monitoring

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Glutamate is the most abundant excitatory amino acid in the brain. In addition to the protein structure, it plays important roles in metabolism, nutrition, and signaling via glutamate receptors. Glutamate is synthesized from glutamine by glutaminase, while it is metabolized to the inhibitory amino acid γ-aminobutyric acid (GABA) by glutamic decarboxylase. Thus, the glutamine-glutamate-GABA cycle plays an important role in both excitatory and inhibitory neurotransmissions via glutamate and GABA receptors. Accumulating evidence suggests that abnormalities in glutamatergic neurotransmission via ionotropic and metabotropic glutamate receptors may play crucial roles in the pathophysiology of a variety of psychiatric, neurologic as well as other peripheral disorders. In this chapter, the author discusses the glutamatergic system as potential clinical biomarkers for human blood and cerebrospinal fluid monitoring.

Cite

CITATION STYLE

APA

Hashimoto, K. (2018). The glutamatergic system as potential clinical biomarkers for blood and cerebrospinal fluid monitoring. In Neuromethods (Vol. 130, pp. 507–521). Humana Press Inc. https://doi.org/10.1007/978-1-4939-7228-9_16

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free